Chen J - Search Results

1

Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma.

Chen J, Jin R, Zhao J, Liu J, Ying H, Yan H, Zhou S, Liang Y, Huang D, Liang X, Yu H, Lin H, Cai X. Chen J, et al. Cancer Lett. 2015 Oct 10;367(1):1-11. doi: 10.1016/j.canlet.2015.06.019. Epub 2015 Jul 10. Cancer Lett. 2015. PMID: 26170167 Review.

2

Sorafenib-resistant hepatocellular carcinoma stratified by phosphorylated ERK activates PD-1 immune checkpoint.

Chen J, Ji T, Zhao J, Li G, Zhang J, Jin R, Liu J, Liu X, Liang X, Huang D, Xie A, Lin H, Cang Y, Cai X. Chen J, et al. Oncotarget. 2016 Jul 5;7(27):41274-41284. doi: 10.18632/oncotarget.8978. Oncotarget. 2016. PMID: 27129180 Free PMC article.

3

Sorafenib with ASC-J9^® synergistically suppresses the HCC progression via altering the pSTAT3-CCL2/Bcl2 signals.

Xu J, Lin H, Li G, Sun Y, Shi L, Ma WL, Chen J, Cai X, Chang C. Xu J, et al. Among authors: chen j. Int J Cancer. 2017 Feb 1;140(3):705-717. doi: 10.1002/ijc.30446. Epub 2016 Nov 9. Int J Cancer. 2017. PMID: 27668844 Free PMC article.

4

The miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals.

Xu J, Lin H, Li G, Sun Y, Chen J, Shi L, Cai X, Chang C. Xu J, et al. Among authors: chen j. EBioMedicine. 2016 Oct;12:55-67. doi: 10.1016/j.ebiom.2016.07.013. Epub 2016 Jul 14. EBioMedicine. 2016. PMID: 27688096 Free PMC article.

5

Sorafenib: A potential therapeutic drug for hepatic fibrosis and its outcomes.

Ma R, Chen J, Liang Y, Lin S, Zhu L, Liang X, Cai X. Ma R, et al. Among authors: chen j. Biomed Pharmacother. 2017 Apr;88:459-468. doi: 10.1016/j.biopha.2017.01.107. Epub 2017 Jan 22. Biomed Pharmacother. 2017. PMID: 28122312 Review.

6

Increasing AR by HIF-2α inhibitor (PT-2385) overcomes the side-effects of sorafenib by suppressing hepatocellular carcinoma invasion via alteration of pSTAT3, pAKT and pERK signals.

Xu J, Zheng L, Chen J, Sun Y, Lin H, Jin RA, Tang M, Liang X, Cai X. Xu J, et al. Among authors: chen j. Cell Death Dis. 2017 Oct 12;8(10):e3095. doi: 10.1038/cddis.2017.411. Cell Death Dis. 2017. PMID: 29022906 Free PMC article.

7

Phosphorylated ERK is a potential prognostic biomarker for Sorafenib response in hepatocellular carcinoma.

Liang Y, Chen J, Yu Q, Ji T, Zhang B, Xu J, Dai Y, Xie Y, Lin H, Liang X, Cai X. Liang Y, et al. Among authors: chen j. Cancer Med. 2017 Dec;6(12):2787-2795. doi: 10.1002/cam4.1228. Epub 2017 Oct 13. Cancer Med. 2017. PMID: 29030911 Free PMC article.

8

Role of cellular, molecular and tumor microenvironment in hepatocellular carcinoma: Possible targets and future directions in the regorafenib era.

Juengpanich S, Topatana W, Lu C, Staiculescu D, Li S, Cao J, Lin J, Hu J, Chen M, Chen J, Cai X. Juengpanich S, et al. Among authors: chen j, chen m. Int J Cancer. 2020 Oct 1;147(7):1778-1792. doi: 10.1002/ijc.32970. Epub 2020 Apr 15. Int J Cancer. 2020. PMID: 32162677 Review.

9

CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1.

Xu J, Ji L, Liang Y, Wan Z, Zheng W, Song X, Gorshkov K, Sun Q, Lin H, Zheng X, Chen J, Jin RA, Liang X, Cai X. Xu J, et al. Among authors: chen j. Signal Transduct Target Ther. 2020 Dec 26;5(1):298. doi: 10.1038/s41392-020-00375-5. Signal Transduct Target Ther. 2020. PMID: 33361760 Free PMC article.

10

Prognostic significance of E-cadherin expression in hepatocellular carcinoma: a meta-analysis.

Chen J, Zhao J, Ma R, Lin H, Liang X, Cai X. Chen J, et al. PLoS One. 2014 Aug 5;9(8):e103952. doi: 10.1371/journal.pone.0103952. eCollection 2014. PLoS One. 2014. PMID: 25093414 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138,053 results

Search Page

Filters